Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV002073409 | SCV002497300 | likely pathogenic | not provided | 2022-03-01 | criteria provided, single submitter | clinical testing | TERT: PS2, PS3:Moderate |
Baylor Genetics | RCV003470881 | SCV004208111 | likely pathogenic | Dyskeratosis congenita, autosomal dominant 2 | 2024-03-28 | criteria provided, single submitter | clinical testing | |
Division of Medical Oncology, |
RCV001728078 | SCV001976515 | pathogenic | Melanoma, cutaneous malignant, susceptibility to, 1 | 2021-01-30 | no assertion criteria provided | clinical testing | |
Caryl and Israel Englander Institute for Precision Medicine, |
RCV002223145 | SCV002500986 | uncertain significance | not specified | no assertion criteria provided | literature only | ||
Laboratory of Urology, |
RCV003332346 | SCV004040468 | pathogenic | Malignant tumor of urinary bladder | no assertion criteria provided | research |